-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Content introduction
Chinese Summary:
.
As one of the essential trace elements for life, iron is essential
for a variety of biological processes including DNA synthesis and repair, cellular respiration, oxygen transport, lipid oxidation, signal transduction and other processes.
Studies have shown that cancer cells increase intracellular iron ion concentrations to promote cell proliferation
through a variety of mechanisms.
Iron death, a form of cell death caused by iron-catalyzed peroxidation of polyunsaturated fatty acids, is a potential therapeutic target for the treatment of drug-resistant tumors
.
As a novel regulatory element, long non-coding RNA (lncRNA) is involved in regulating various cellular processes
such as cell metabolism, proliferation, apoptosis, and iron death.
In this review, we summarised the relationship between
iron metabolism, iron death, and lncRNA in tumorigenesis.
An in-depth discussion of the role of lncRNA in tumor iron death will provide new strategies and perspectives
for jointly targeting lncRNA and iron death-related molecules in tumor treatment.
Keyword groups:
Author:
Lei QU, Xinyu HE, Qian TANG, Xiao FAN, Jian LIU, Aifu LIN
Citation format of this article:
Lei QU, Xinyu HE, Qian TANG, Xiao FAN, Jian LIU, Aifu LIN.
Ironmetabolism, ferroptosis, and lncRNA in cancer: knowns and unknowns[J].
Journalof Zhejiang University Science B, 2022, 23(10): 844-862.
https://doi.
org/10.
1631/jzus.
B2200194
Full text download address: https://jzus.
zju.
edu.
cn/oldversion/opentxt.
php?doi=10.
1631/jzus.
B2200194
About this journal
Journal of Zhejiang University (English Edition) Series B: Biomedicine and Biotechnology, referred to as JZUS-B, is a comprehensive English monthly journal
of biology.
JZUS-B has been included in SCI-E since 2008, with a latest impact factor of 5.
552, and has been searched
by well-known domestic and foreign platforms such as MEDLINE/PubMed, PMC, Scopus, BA, BIOSIS Previews, etc.
JZUS-B receives articles in life sciences, medicine, pharmacy, biochemistry, biotechnology and bioengineering, agronomy, ecology, and zoology
.
Article types include Review, Article, Perspective, Viewpoint, Editorial, Correspondence, etc
.
The journal has always implemented a strict international peer review mechanism, with an average review period of 42 days and an average acceptance time of 53 days
.
After acceptance, the article will be immediately online in Press and will generally be officially published
within 2 months.
"Content-oriented, flexible form" is the characteristic of
this journal.
JZUS-B welcomes outstanding scholars at home and abroad to submit the latest scientific research achievements, controversial topics, review papers and organize the publication of hot albums
.
Journal Springer homepage:
style="min-height: 14px;outline: 0px;max-width: 536px;box-sizing: border-box;overflow-wrap: break-word !important;" _msthash="251726" _msttexthash="586040">Online Submission Address:
style="outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;">
Contact us
Zhejiang University Journal English version is a number of English academic journals of the general name, the scope of collection covers all directions of science, engineering, agriculture and medicine, welcome to submit to our journal, you can pay attention to our journal public number zdxbywb for more information
.